9267.T
Genky DrugStores Co.,Ltd.
プライム · 小売業 · 小売 · JP
JPY 3,550.00
−0.70%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 211.3B | 200.8B | 184.9B | 169.1B | 154.6B |
| Cost of Revenue | 44.7B | 159.9B | 147.2B | 134.5B | 123.7B |
| Gross Profit | 11.3B | 40.9B | 37.6B | 34.6B | 31.0B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 8.4B | 31.2B | 28.6B | 27.8B | 25.3B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 8.4B | 31.2B | 28.6B | 27.8B | 25.3B |
| Cost and Expenses | 200.5B | 191.1B | 175.8B | 162.3B | 149.0B |
| Operating Income (EBIT) | 10.8B | 9.7B | 9.0B | 6.7B | 5.7B |
| Non-Operating | |||||
| Interest Income | 5.0M | 10.0M | 7.0M | 8.0M | 9.0M |
| Interest Expense | 62.0M | 216.0M | 103.0M | 70.0M | 59.1M |
| Net Interest Income | (57.0M) | (206.0M) | (96.0M) | (62.0M) | (50.1M) |
| Other Non-Op Income/Expense | 43.0M | 241.0M | 253.0M | 370.0M | 412.1M |
| Non-Operating Income (excl Interest) | 215.0M | 831.0M | 662.0M | 768.0M | 780.9M |
| EBT (Pre-Tax Income) | 3.0B | 9.9B | 8.8B | 6.7B | 6.1B |
| Income Tax Expense | 919.0M | 2.8B | 2.5B | 1.9B | 1.7B |
| Bottom Line | |||||
| Net Income | 7.8B | 7.1B | 6.3B | 4.8B | 4.4B |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 7.8B | 7.1B | 6.3B | 4.8B | 4.4B |
| Per Share | |||||
| Basic EPS | ¥257 | ¥233 | ¥208 | ¥314 | ¥291 |
| Diluted EPS | ¥257 | ¥232 | ¥208 | ¥314 | ¥291 |
| Revenue Per Share | ¥6,943 | ¥6,606 | ¥6,086 | ¥11,135 | ¥10,187 |
| Shares | |||||
| Basic Shares Outstanding | 30.4M | 30.4M | 30.4M | 15.2M | 15.2M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | 15.9B | 14.6B | 11.7B | 10.3B |
| D&A | — | 6.3B | 5.6B | 5.0B | 4.6B |
| EBIT | 10.8B | 9.7B | 9.0B | 6.7B | 5.7B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026